2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene

C104H82N8 — CID 102274438

IUPAC2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene
SMILESCc1ccc(/C2=C3\C=CC(=N3)/C(c3ccc(C)cc3)=c3/cc/c([nH]3)=C(\c3ccc(C)cc3)C3=N/C(=C(/c4ccc(C)cc4)C4=NC=C2C4Cc2ccccc2CC2C4=CN=C2/C(c2ccc(C)cc2)=C2/C=CC(=N2)/C(c2ccc(C)cc2)=c2/cc/c([nH]2)=C(\c2ccc(C)cc2)C2=N/C(=C\4c4ccc(C)cc4)C=C2)C=C3)cc1
InChIInChI=1S/C104H82N8/c1-61-13-29-69(30-14-61)95-81-59-105-103(101(75-41-25-67(7)26-42-75)93-55-53-91(111-93)99(73-37-21-65(5)22-38-73)89-51-49-87(109-89)97(85-47-45-83(95)107-85)71-33-17-63(3)18-34-71)79(81)57-77-11-9-10-12-78(77)58-80-82-60-106-104(80)102(76-43-27-68(8)28-44-76)94-56-54-92(112-94)100(74-39-23-66(6)24-40-74)90-52-50-88(110-90)98(72-35-19-64(4)20-36-72)86-48-46-84(108-86)96(82)70-31-15-62(2)16-32-70/h9-56,59-60,79-80,109-110H,57-58H2,1-8H3/b95-81-,95-83-,96-82-,96-84-,97-85-,97-87-,98-86-,98-88-,99-89-,99-91-,100-90-,100-92-,101-93-,102-94-,103-101+,104-102+
InChIKeyDAYOVOGYZJUHCP-XPLABXKYSA-N
MW1443.86 g/mol
LogP19.72
Rot. Bonds12

About 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene

2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene (PubChem CID 102274438) has the molecular formula C104H82N8 and a molecular weight of 1443.86 g/mol. Its IUPAC name is 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene.

Molecular Properties

Compound Name2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene
PubChem CID102274438
Molecular FormulaC104H82N8
Molecular Weight1443.86 g/mol
Exact Mass1442.67
IUPAC Name2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene
SMILESCc1ccc(/C2=C3\C=CC(=N3)/C(c3ccc(C)cc3)=c3/cc/c([nH]3)=C(\c3ccc(C)cc3)C3=N/C(=C(/c4ccc(C)cc4)C4=NC=C2C4Cc2ccccc2CC2C4=CN=C2/C(c2ccc(C)cc2)=C2/C=CC(=N2)/C(c2ccc(C)cc2)=c2/cc/c([nH]2)=C(\c2ccc(C)cc2)C2=N/C(=C\4c4ccc(C)cc4)C=C2)C=C3)cc1
InChIInChI=1S/C104H82N8/c1-61-13-29-69(30-14-61)95-81-59-105-103(101(75-41-25-67(7)26-42-75)93-55-53-91(111-93)99(73-37-21-65(5)22-38-73)89-51-49-87(109-89)97(85-47-45-83(95)107-85)71-33-17-63(3)18-34-71)79(81)57-77-11-9-10-12-78(77)58-80-82-60-106-104(80)102(76-43-27-68(8)28-44-76)94-56-54-92(112-94)100(74-39-23-66(6)24-40-74)90-52-50-88(110-90)98(72-35-19-64(4)20-36-72)86-48-46-84(108-86)96(82)70-31-15-62(2)16-32-70/h9-56,59-60,79-80,109-110H,57-58H2,1-8H3/b95-81-,95-83-,96-82-,96-84-,97-85-,97-87-,98-86-,98-88-,99-89-,99-91-,100-90-,100-92-,101-93-,102-94-,103-101+,104-102+
InChIKeyDAYOVOGYZJUHCP-XPLABXKYSA-N
XLogP19.72
TPSA105.74 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds12
Heavy Atoms112
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001443.86
LogP ≤ 519.72
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene?
The IUPAC name of 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene (CID 102274438) is 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene.
What is the SMILES notation for 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene?
The canonical SMILES for 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene is Cc1ccc(/C2=C3\C=CC(=N3)/C(c3ccc(C)cc3)=c3/cc/c([nH]3)=C(\c3ccc(C)cc3)C3=N/C(=C(/c4ccc(C)cc4)C4=NC=C2C4Cc2ccccc2CC2C4=CN=C2/C(c2ccc(C)cc2)=C2/C=CC(=N2)/C(c2ccc(C)cc2)=c2/cc/c([nH]2)=C(\c2ccc(C)cc2)C2=N/C(=C\4c4ccc(C)cc4)C=C2)C=C3)cc1.
What is the InChIKey of 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene?
The InChIKey is DAYOVOGYZJUHCP-XPLABXKYSA-N. The full InChI is InChI=1S/C104H82N8/c1-61-13-29-69(30-14-61)95-81-59-105-103(101(75-41-25-67(7)26-42-75)93-55-53-91(111-93)99(73-37-21-65(5)22-38-73)89-51-49-87(109-89)97(85-47-45-83(95)107-85)71-33-17-63(3)18-34-71)79(81)57-77-11-9-10-12-78(77)58-80-82-60-106-104(80)102(76-43-27-68(8)28-44-76)94-56-54-92(112-94)100(74-39-23-66(6)24-40-74)90-52-50-88(110-90)98(72-35-19-64(4)20-36-72)86-48-46-84(108-86)96(82)70-31-15-62(2)16-32-70/h9-56,59-60,79-80,109-110H,57-58H2,1-8H3/b95-81-,95-83-,96-82-,96-84-,97-85-,97-87-,98-86-,98-88-,99-89-,99-91-,100-90-,100-92-,101-93-,102-94-,103-101+,104-102+.
What are the key properties of 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene?
2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene has a molecular weight of 1443.86 g/mol, XLogP of 19.72, 12 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2,7,12,17-tetrakis(4-methylphenyl)-24-[[2-[[2,7,12,17-tetrakis(4-methylphenyl)-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-24-yl]methyl]phenyl]methyl]-4,21,22,23-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene is sourced from PubChem (CID 102274438), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).